Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "CompassHER2 RD Trial - Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients With Residual HER2+ Invasive BC"
By
Insights from 2023 SABCS
FEATURING
Ciara O'Sullivan
By
Insights from 2023 SABCS
FEATURING
Ciara O'Sullivan
290 views
December 15, 2023
Login to view comments.
Click here to Login
Videos